AstraZeneca invests over $100 million in global health program
Pharmaceutical company AstraZeneca has announced a major investment in its "Young Health Programme" initiative. The company will invest over $100 million in the project, which aims to support the health of young people around the world.
The program is focused on the prevention of non-communicable diseases, such as diabetes, cancer, and cardiovascular problems. The main goal of the initiative is to promote a healthy lifestyle and inform young people about the risks associated with smoking, unhealthy eating, and a lack of physical activity.
The company confirmed that the project will continue its active operations until 2030. Through these funds, AstraZeneca plans to expand the reach of its educational campaigns and support local organizations that work with adolescents in various countries.
The investment is part of the company's long-term social responsibility strategy. The "Young Health Programme" aims to reduce the number of chronic diseases among the younger generation by ensuring better health literacy and access to quality information.
This initiative is an important step toward improving public health on a global scale. The long-term funding is expected to enable millions of young people to make better choices for their future and their health.